Bencyclane

CARDIOVASCULAR SYSTEM

Key facts

Bencyclane is a drug catalogued in DrugCentral. Recorded indications include Cerebrovascular disease.

• Indications: Cerebrovascular disease.
• ATC code: C04AX11 (Other peripheral vasodilators).
• Molecular formula: C19H31NO; molecular weight 289.46 g/mol.

Indications & contraindications

Drug–disease relationships curated by DrugCentral (OMOP / SNOMED concepts).

Indications (1)

• Cerebrovascular disease

ATC classification

ATC code	Therapeutic hierarchy
C04AX11	CARDIOVASCULAR SYSTEM › PERIPHERAL VASODILATORS › PERIPHERAL VASODILATORS › Other peripheral vasodilators

Chemical structure

Full physicochemical, ADMET and 3D-structure analysis of Bencyclane is on its molecule page.

• Molecular formula: C₁₉H₃₁NO
• Molecular weight: 289.46 g/mol
• CAS number: —
• InChIKey: FYJJXENSONZJRG-UHFFFAOYSA-N
• PubChem CID: 2312

CN(C)CCCOC1(CC2=CC=CC=C2)CCCCCC1

Frequently asked questions

Answers are generated from the structured data on this page, not written by hand.

What is Bencyclane used for?

DrugCentral lists the following indications for Bencyclane: Cerebrovascular disease.

What is the chemical formula of Bencyclane?

Bencyclane has the molecular formula C19H31NO and a molecular weight of 289.46 g/mol.

Sources

• DrugCentral drug card 301 — structure, indications, targets, approvals, pharmacologic classes (CC BY-SA 4.0)
• ChEMBL CHEMBL2105930 — compound record and bioactivity
• PubChem CID 2312 — chemical identifiers
• DrugBank DB13488 — drug record
• FDA UNII 6I97Z6S135 — substance identity

How this page is built: methodology · editorial policy & corrections.